Dornoosh Zonoobi, Ph.D.

Dornoosh is Exo’s Vice President of Artificial Intelligence. She has more than 12 years of experience in leading machine learning research and development in the field of medical imaging. Most recently, Dornoosh was the co-founder & CEO of Medo.ai, a health-tech startup focused on developing cutting-edge AI technologies to simplify the use of ultrasound, that was acquired by Exo. She led Medo from the idea to two FDA-cleared products, and deployment in four countries, along with major commercial partnerships. To date, she has filed 8 patents and has more than 30 peer-review publications in the area of medical image processing. She is also a member of the Commercialization Working Group of the Government of Canada’s Advisory Council on Artificial Intelligence. Dornoosh earned her Master's and PhD in the area of computer vision and machine learning from the National University of Singapore and completed her post-doctoral fellowship in 3D Ultrasound analysis at the Radiology department of the University of Alberta, Canada.